These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

192 related items for PubMed ID: 1980930

  • 21. Comparison of the effects of doxazosin and atenolol on blood pressure and blood lipids: a one-year, double-blind study in 228 hypertensive patients.
    Talseth T, Westlie L, Daae L, Vatle S.
    Am Heart J; 1988 Dec; 116(6 Pt 2):1790-6. PubMed ID: 2904752
    [Abstract] [Full Text] [Related]

  • 22. Doxazosin therapy in the treatment of diabetic hypertension.
    Feher MD.
    Am Heart J; 1991 Apr; 121(4 Pt 2):1294-301. PubMed ID: 1826186
    [Abstract] [Full Text] [Related]

  • 23. [Use of doxazosin (Cardura-Pfizer), alpha 1-adrenoreceptor antagonist, in treatment of hypertension in patients with diabetes].
    Grzeszczak W.
    Wiad Lek; 1998 Apr; 51 Suppl 2():5-10. PubMed ID: 9686527
    [Abstract] [Full Text] [Related]

  • 24. The role of alpha 1-blockers in combination therapy for hypertension.
    Zusman RM.
    Int J Clin Pract; 2000 Apr; 54(1):36-40. PubMed ID: 10750258
    [Abstract] [Full Text] [Related]

  • 25. Metabolic outcome during 1 year in newly detected hypertensives: results of the Antihypertensive Treatment and Lipid Profile in a North of Sweden Efficacy Evaluation (ALPINE study).
    Lindholm LH, Persson M, Alaupovic P, Carlberg B, Svensson A, Samuelsson O.
    J Hypertens; 2003 Aug; 21(8):1563-74. PubMed ID: 12872052
    [Abstract] [Full Text] [Related]

  • 26. Acute effects of doxazosin and atenolol on smoking-induced peripheral vasoconstriction in hypertensive habitual smokers.
    Lecerof H, Bornmyr S, Lilja B, De Pedis G, Hulthén UL.
    J Hypertens Suppl; 1990 Sep; 8(5):S29-33. PubMed ID: 1981074
    [Abstract] [Full Text] [Related]

  • 27. Effect of losartan, compared with atenolol, on endothelial function and oxidative stress in patients with type 2 diabetes and hypertension.
    Flammer AJ, Hermann F, Wiesli P, Schwegler B, Chenevard R, Hürlimann D, Sudano I, Gay S, Neidhart M, Riesen W, Ruschitzka F, Lüscher TF, Noll G, Lehmann R.
    J Hypertens; 2007 Apr; 25(4):785-91. PubMed ID: 17351370
    [Abstract] [Full Text] [Related]

  • 28. Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus.
    Petersen KR.
    Dan Med Bull; 2002 Feb; 49(1):43-60. PubMed ID: 11894723
    [Abstract] [Full Text] [Related]

  • 29. A double-blind parallel trial to assess the efficacy of doxazosin, atenolol and placebo in patients with mild to moderate systemic hypertension.
    Nash DT, Schonfeld G, Reeves RL, Black H, Weidler DJ.
    Am J Cardiol; 1987 May 29; 59(14):87G-90G. PubMed ID: 2884859
    [Abstract] [Full Text] [Related]

  • 30. Multicenter, double-blind comparison of doxazosin and atenolol in patients with mild to moderate hypertension.
    Ott P, Storm TL, Krusell LR, Jensen H, Badskjaer J, Faergeman O.
    Am J Cardiol; 1987 May 29; 59(14):73G-77G. PubMed ID: 2884856
    [Abstract] [Full Text] [Related]

  • 31. Lipids and lipoproteins during antihypertensive drug therapy. Comparison of doxazosin and atenolol in a randomized, double-blind trial: the Alpha Beta Canada Study.
    Rabkin SW, Huff MW, Newman C, Sim D, Carruthers SG.
    Hypertension; 1994 Aug 29; 24(2):241-8. PubMed ID: 8039850
    [Abstract] [Full Text] [Related]

  • 32. Double-blind comparison of the effects of long-term treatment with doxazosin or atenolol on serum lipoproteins.
    Lehtonen A, Himanen P, Saraste M, Niittymäki K, Marniemi J.
    Br J Clin Pharmacol; 1986 Aug 29; 21 Suppl 1(Suppl 1):77S-81S. PubMed ID: 2939871
    [Abstract] [Full Text] [Related]

  • 33. A comparative study of doxazosin versus atenolol in mild-to-moderate hypertension.
    Giorgi G, Legramante JM, Fioravanti G, Paies G, Legramante A.
    Am Heart J; 1988 Dec 29; 116(6 Pt 2):1801-5. PubMed ID: 2904754
    [Abstract] [Full Text] [Related]

  • 34. [The effect of doxazosin on blood pressure, lipids, fibrinogen and plasminogen activator inhibitor. A comparative study among smokers and non-smokers with essential hypertension].
    Daae LN, Kierulf P, Brusletto B, Westheim A, Holme I, Syvertsen JO.
    Tidsskr Nor Laegeforen; 1991 Apr 10; 111(9):1102-5. PubMed ID: 1827216
    [Abstract] [Full Text] [Related]

  • 35. The antihypertensive and metabolic effects of low and conventional dose cyclopenthiazide in type II diabetics with hypertension.
    Passmore AP, Whitehead EM, Crawford V, McVeigh GE, Johnston GD.
    Q J Med; 1991 Nov 10; 81(295):919-28. PubMed ID: 1808632
    [Abstract] [Full Text] [Related]

  • 36. Alpha 1-blocker doxazosin improves peripheral insulin sensitivity in diabetic hypertensive patients.
    Giorda C, Appendino M, Mason MG, Imperiale E, Pagano G.
    Metabolism; 1995 May 10; 44(5):673-6. PubMed ID: 7752918
    [Abstract] [Full Text] [Related]

  • 37. Comparative effects of nebivolol and atenolol on blood pressure and insulin sensitivity in hypertensive subjects with type II diabetes.
    Fogari R, Zoppi A, Lazzari P, Mugellini A, Lusardi P, Preti P, Van Nueten L, Vertommen C.
    J Hum Hypertens; 1997 Nov 10; 11(11):753-7. PubMed ID: 9416986
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.